{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:20:50Z","timestamp":1790014850651,"version":"4.0.1"},"posted":{"date-parts":[[2024,6,25]]},"group-title":"In Review","reference-count":52,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY017017"],"award-info":[{"award-number":["R01EY017017"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY030904"],"award-info":[{"award-number":["R01EY030904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Children's Hospital","doi-asserted-by":"publisher","award":["IDDRC (1U54HD090255)"],"award-info":[{"award-number":["IDDRC (1U54HD090255)"]}],"id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Children's Hospital","doi-asserted-by":"publisher","award":["Technology Development Fund"],"award-info":[{"award-number":["Technology Development Fund"]}],"id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001862","name":"Svenska Forskningsr\u00e5det Formas","doi-asserted-by":"publisher","award":["DNR# #2020-01092"],"award-info":[{"award-number":["DNR# #2020-01092"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY032492"],"award-info":[{"award-number":["R01EY032492"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Children's Hospital","doi-asserted-by":"publisher","award":["OFD\/BTREC\/CTREC Faculty Career Development Grant 97906"],"award-info":[{"award-number":["OFD\/BTREC\/CTREC Faculty Career Development Grant 97906"]}],"id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Children's Hospital","doi-asserted-by":"publisher","award":["Pilot Grant 92214"],"award-info":[{"award-number":["Pilot Grant 92214"]}],"id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Children's Hospital","doi-asserted-by":"publisher","award":["Ophthalmology Foundation 85010"],"award-info":[{"award-number":["Ophthalmology Foundation 85010"]}],"id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL126901"],"award-info":[{"award-number":["R01HL126901"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL149302"],"award-info":[{"award-number":["R01HL149302"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,6,21]]},"abstract":"<title>Abstract<\/title>\n        <p>Pathological neovascularization in retinopathy of prematurity (ROP) can cause visual impairment in preterm infants. Current ROP treatments which are not preventative and only address late neovascular ROP, are costly and can lead to severe complications. We showed that topical 0.1% dexamethasone eye drops administered prior to peak neovessel formation prevented neovascularization in five extremely preterm infants at high risk for ROP and suppressed neovascularization by 30% in mouse oxygen-induced retinopathy (OIR) modeling ROP. In contrast, in OIR, topical dexamethasone treatment before any neovessel formation had limited efficacy in preventing later neovascularization, while treatment after peak neovessel formation had a non-statistically significant trend to exacerbating disease. Optimally timed topical dexamethasone suppression of neovascularization in OIR was associated with increased retinal mitochondrial gene expression and decreased inflammatory marker expression, predominantly found in immune cells. Blocking mitochondrial ATP synthetase reversed the inhibitory effect of dexamethasone on neovascularization in OIR. This study provides new insights into topical steroid effects in retinal neovascularization and into mitochondrial function in phase II ROP, and suggests a simple clinical approach to prevent severe ROP.<\/p>","DOI":"10.21203\/rs.3.rs-4619093\/v1","type":"posted-content","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T14:10:31Z","timestamp":1719324631000},"source":"Crossref","is-referenced-by-count":1,"title":["Timed topical dexamethasone eye drops improve mitochondrial function to prevent severe retinopathy of prematurity."],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5199-1970","authenticated-orcid":false,"given":"Hitomi","family":"Yagi","sequence":"first","affiliation":[{"name":"Boston Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Boeck","sequence":"additional","affiliation":[{"name":"Boston Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Petrishka-Lozenska","sequence":"additional","affiliation":[{"name":"University of Gothenburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Lundgren","sequence":"additional","affiliation":[{"name":"University of Gothenburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Kasai","sequence":"additional","affiliation":[{"name":"Brigham Women's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gael","family":"Cagnone","sequence":"additional","affiliation":[{"name":"CHU Sainte-Justine, Universit\u00e9 de Montr\u00e9al"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"gael.cagnone.1@gmail.com","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaomei","family":"Wang","sequence":"additional","affiliation":[{"name":"Boston Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Lee","sequence":"additional","affiliation":[{"name":"Boston Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Tomita","sequence":"additional","affiliation":[{"name":"Keio University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha A.","family":"Singh","sequence":"additional","affiliation":[{"name":"Brigham Women's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-S\u00e9bastien","family":"Joyal","sequence":"additional","affiliation":[{"name":"CHU Sainte-Justine, Universit\u00e9 de Montr\u00e9al"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Aikawa","sequence":"additional","affiliation":[{"name":"Brigham Women's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuno","family":"Negishi","sequence":"additional","affiliation":[{"name":"Keio University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Fu","sequence":"additional","affiliation":[{"name":"Boston Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9259-1244","authenticated-orcid":false,"given":"Ann","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[{"name":"University of Gothenburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7644-6410","authenticated-orcid":false,"given":"Lois E.H.","family":"Smith","sequence":"additional","affiliation":[{"name":"Boston Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"9902","key":"ref1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstrom A","year":"2013","unstructured":"Hellstrom A, Smith LE, Dammann O (2013) Retinopathy of prematurity. Lancet 382(9902):1445\u20131457. 10.1016\/S0140-6736(13)60178-6","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80550","article-title":"Retinopathy of prematurity: Metabolic risk factors","volume":"11","author":"Fu Z","year":"2022","unstructured":"Fu Z, Nilsson AK, Hellstrom A, Smith LEH (2022) Retinopathy of prematurity: Metabolic risk factors. Elife 11. 10.7554\/eLife.80550","journal-title":"Elife"},{"issue":"2","key":"ref3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato T","year":"2012","unstructured":"Sato T, Wada K, Arahori H, Kuno N, Imoto K, Iwahashi-Shima C, Kusaka S (2012) Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity. Am J Ophthalmol 153(2):327\u2013333e321. 10.1016\/j.ajo.2011.07.005","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"ref4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s11892-022-01491-y","article-title":"Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: a Review","volume":"22","author":"Zehden JA","year":"2022","unstructured":"Zehden JA, Mortensen XM, Reddy A, Zhang AY (2022) Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: a Review. Curr Diab Rep 22(10):525\u2013536. 10.1007\/s11892-022-01491-y","journal-title":"Curr Diab Rep"},{"issue":"10","key":"ref5","first-page":"3095","article-title":"Dexamethasone and critical effect of timing on retinopathy","volume":"41","author":"Yossuck P","year":"2000","unstructured":"Yossuck P, Yan Y, Tadesse M, Higgins RD (2000) Dexamethasone and critical effect of timing on retinopathy. Invest Ophthalmol Vis Sci 41(10):3095\u20133099","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"ref6","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2353\/ajpath.2007.070172","article-title":"Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis","volume":"171","author":"Nakao S","year":"2007","unstructured":"Nakao S, Hata Y, Miura M, Noda K, Kimura YN, Kawahara S, Kita T, Hisatomi T, Nakazawa T, Jin Y, Dana MR, Kuwano M, Ono M, Ishibashi T, Hafezi-Moghadam A (2007) Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis. Am J Pathol 171(3):1058\u20131065. 10.2353\/ajpath.2007.070172","journal-title":"Am J Pathol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2147\/DMSO.S73540","article-title":"Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant","volume":"8","author":"Cebeci Z","year":"2015","unstructured":"Cebeci Z, Kir N (2015) Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant. Diabetes Metab Syndr Obes 8:555\u2013566. 10.2147\/DMSO.S73540","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"ref8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1203\/00006450-199907000-00016","article-title":"Dexamethasone reduces oxygen induced retinopathy in a mouse model","volume":"46","author":"Rotschild T","year":"1999","unstructured":"Rotschild T, Nandgaonkar BN, Yu K, Higgins RD (1999) Dexamethasone reduces oxygen induced retinopathy in a mouse model. Pediatr Res 46(1):94\u2013100. 10.1203\/00006450-199907000-00016","journal-title":"Pediatr Res"},{"issue":"3","key":"ref9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1203\/00006450-199903000-00004","article-title":"Hyperoxia and glucocorticoid modify retinal vessel growth and interleukin-1 receptor antagonist in newborn rabbits","volume":"45","author":"Lawas-Alejo PA","year":"1999","unstructured":"Lawas-Alejo PA, Slivka S, Hernandez H, Bry K, Hallman M (1999) Hyperoxia and glucocorticoid modify retinal vessel growth and interleukin-1 receptor antagonist in newborn rabbits. Pediatr Res 45(3):313\u2013317. 10.1203\/00006450-199903000-00004","journal-title":"Pediatr Res"},{"issue":"7","key":"ref10","first-page":"1653","article-title":"Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor","volume":"42","author":"Wenzel A","year":"2001","unstructured":"Wenzel A, Grimm C, Seeliger MW, Jaissle G, Hafezi F, Kretschmer R, Zrenner E, Reme CE (2001) Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor. Invest Ophthalmol Vis Sci 42(7):1653\u20131659","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"ref11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/0014-4835(92)90137-h","article-title":"Dexamethasone ameliorates retinal photic injury in albino rats","volume":"54","author":"Fu J","year":"1992","unstructured":"Fu J, Lam TT, Tso MO (1992) Dexamethasone ameliorates retinal photic injury in albino rats. Exp Eye Res 54(4):583\u2013594. 10.1016\/0014-4835(92)90137-h","journal-title":"Exp Eye Res"},{"issue":"11","key":"ref12","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1167\/iovs.07-1154","article-title":"Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization","volume":"49","author":"She H","year":"2008","unstructured":"She H, Nakazawa T, Matsubara A, Connolly E, Hisatomi T, Noda K, Kim I, Gragoudas ES, Miller JW (2008) Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization. Invest Ophthalmol Vis Sci 49(11):5008\u20135014. 10.1167\/iovs.07-1154","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.expneurol.2015.08.007","article-title":"Activation of glucocorticoid receptors in Muller glia is protective to retinal neurons and suppresses microglial reactivity","volume":"273","author":"Gallina D","year":"2015","unstructured":"Gallina D, Zelinka CP, Cebulla CM, Fischer AJ (2015) Activation of glucocorticoid receptors in Muller glia is protective to retinal neurons and suppresses microglial reactivity. Exp Neurol 273:114\u2013125. 10.1016\/j.expneurol.2015.08.007","journal-title":"Exp Neurol"},{"issue":"2","key":"ref14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/ng984","article-title":"Evidence for two apoptotic pathways in light-induced retinal degeneration","volume":"32","author":"Hao W","year":"2002","unstructured":"Hao W, Wenzel A, Obin MS, Chen CK, Brill E, Krasnoperova NV, Eversole-Cire P, Kleyner Y, Taylor A, Simon MI, Grimm C, Reme CE, Lem J (2002) Evidence for two apoptotic pathways in light-induced retinal degeneration. Nat Genet 32(2):254\u2013260. 10.1038\/ng984","journal-title":"Nat Genet"},{"issue":"7","key":"ref15","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41423-022-00859-0","article-title":"Glucocorticoid receptor modulates myeloid-derived suppressor cell function via mitochondrial metabolism in immune thrombocytopenia","volume":"19","author":"Hou Y","year":"2022","unstructured":"Hou Y, Xie J, Wang S, Li D, Wang L, Wang H, Ni X, Leng S, Li G, Hou M, Peng J (2022) Glucocorticoid receptor modulates myeloid-derived suppressor cell function via mitochondrial metabolism in immune thrombocytopenia. Cell Mol Immunol 19(7):764\u2013776. 10.1038\/s41423-022-00859-0","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"ref16","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International Classification of Retinopathy of Prematurity, Third Edition","volume":"128","author":"Chiang MF","year":"2021","unstructured":"Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A, Binenbaum G, Blair M, Peter Campbell J, Capone A Jr., Chen Y, Dai S, Ells A, Fleck BW, Good WV, Elizabeth Hartnett M, Holmstrom G, Kusaka S, Kychenthal A, Lepore D, Lorenz B, Martinez-Castellanos MA, Ozdek S, Ademola-Popoola D, Reynolds JD, Shah PK, Shapiro M, Stahl A, Toth C, Vinekar A, Visser L, Wallace DK, Wu WC, Zhao P, Zin A (2021) International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology 128(10):e51\u2013e68. 10.1016\/j.ophtha.2021.05.031","journal-title":"Ophthalmology"},{"issue":"2","key":"ref17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.oret.2021.09.002","article-title":"Dexamethasone Eye Drops for the Treatment of Retinopathy of Prematurity","volume":"6","author":"Ohnell HM","year":"2022","unstructured":"Ohnell HM, Andreasson S, Granse L (2022) Dexamethasone Eye Drops for the Treatment of Retinopathy of Prematurity. Ophthalmol Retina 6(2):181\u2013182. 10.1016\/j.oret.2021.09.002","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"ref18","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith LE","year":"1994","unstructured":"Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35(1):101\u2013111","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"ref19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity revisited","volume":"123","author":"International Committee for the Classification of Retinopathy of P","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of P (2005) The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 123(7):991\u2013999. 10.1001\/archopht.123.7.991","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"ref20","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.2353\/ajpath.2010.100526","article-title":"Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy","volume":"177","author":"Stahl A","year":"2010","unstructured":"Stahl A, Chen J, Sapieha P, Seaward MR, Krah NM, Dennison RJ, Favazza T, Bucher F, Lofqvist C, Ong H, Hellstrom A, Chemtob S, Akula JD, Smith LE (2010) Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy. Am J Pathol 177(6):2715\u20132723. 10.2353\/ajpath.2010.100526","journal-title":"Am J Pathol"},{"issue":"11","key":"ref21","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor KM","year":"2009","unstructured":"Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, Guerin KI, Sapieha P, Stahl A, Willett KL, Smith LE (2009) Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 4(11):1565\u20131573. 10.1038\/nprot.2009.187","journal-title":"Nat Protoc"},{"issue":"4","key":"ref22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kramer A","year":"2014","unstructured":"Kramer A, Green J, Pollard J Jr., Tugendreich S (2014) Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30(4):523\u2013530. 10.1093\/bioinformatics\/btt703","journal-title":"Bioinformatics"},{"issue":"6506","key":"ref23","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay5356","article-title":"Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy","volume":"369","author":"Binet F","year":"2020","unstructured":"Binet F, Cagnone G, Crespo-Garcia S, Hata M, Neault M, Dejda A, Wilson AM, Buscarlet M, Mawambo GT, Howard JP, Diaz-Marin R, Parinot C, Guber V, Pilon F, Juneau R, Laflamme R, Sawchyn C, Boulay K, Leclerc S, Abu-Thuraia A, Cote JF, Andelfinger G, Rezende FA, Sennlaub F, Joyal JS, Mallette FA, Sapieha P (2020) Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy. Science 369(6506). 10.1126\/science.aay5356","journal-title":"Science"},{"issue":"4","key":"ref24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.mito.2013.04.005","article-title":"Modifiers of the oligomycin sensitivity of the mitochondrial F1F0-ATPase","volume":"13","author":"Pagliarani A","year":"2013","unstructured":"Pagliarani A, Nesci S, Ventrella V (2013) Modifiers of the oligomycin sensitivity of the mitochondrial F1F0-ATPase. Mitochondrion 13(4):312\u2013319. 10.1016\/j.mito.2013.04.005","journal-title":"Mitochondrion"},{"issue":"8","key":"ref25","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1001\/archpedi.1994.02170080078015","article-title":"Lack of association of glucocorticoid therapy and retinopathy of prematurity","volume":"148","author":"Wright K","year":"1994","unstructured":"Wright K, Wright SP (1994) Lack of association of glucocorticoid therapy and retinopathy of prematurity. Arch Pediatr Adolesc Med 148(8):848\u2013852. 10.1001\/archpedi.1994.02170080078015","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1542\/peds.90.4.529","article-title":"Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia","volume":"90","author":"Sobel DB","year":"1992","unstructured":"Sobel DB, Philip AG (1992) Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia. Pediatrics 90(4):529\u2013533","journal-title":"Pediatrics"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"759742","DOI":"10.3389\/fphar.2022.759742","article-title":"Beyond Fetal Immunity: A Systematic Review and Meta-Analysis of the Association Between Antenatal Corticosteroids and Retinopathy of Prematurity","volume":"13","author":"Zeng Y","year":"2022","unstructured":"Zeng Y, Ge G, Lei C, Zhang M (2022) Beyond Fetal Immunity: A Systematic Review and Meta-Analysis of the Association Between Antenatal Corticosteroids and Retinopathy of Prematurity. Front Pharmacol 13:759742. 10.3389\/fphar.2022.759742","journal-title":"Front Pharmacol"},{"issue":"4","key":"ref28","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jaapos.2016.05.008","article-title":"Postnatal corticosteroids and risk of retinopathy of prematurity","volume":"20","author":"Movsas TZ","year":"2016","unstructured":"Movsas TZ, Spitzer AR, Gewolb IH (2016) Postnatal corticosteroids and risk of retinopathy of prematurity. J AAPOS 20(4):348\u2013352. 10.1016\/j.jaapos.2016.05.008","journal-title":"J AAPOS"},{"issue":"4","key":"ref29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4161\/cib.2.4.8554","article-title":"Glucocorticoid receptors modulate mitochondrial function: A novel mechanism for neuroprotection","volume":"2","author":"Du J","year":"2009","unstructured":"Du J, McEwen B, Manji HK (2009) Glucocorticoid receptors modulate mitochondrial function: A novel mechanism for neuroprotection. Commun Integr Biol 2(4):350\u2013352. 10.4161\/cib.2.4.8554","journal-title":"Commun Integr Biol"},{"issue":"11","key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22116054","article-title":"Mitochondrial Glucocorticoid Receptors and Their Actions","volume":"22","author":"Kokkinopoulou I","year":"2021","unstructured":"Kokkinopoulou I, Moutsatsou P (2021) Mitochondrial Glucocorticoid Receptors and Their Actions. Int J Mol Sci 22(11). 10.3390\/ijms22116054","journal-title":"Int J Mol Sci"},{"issue":"32","key":"ref31","doi-asserted-by":"publisher","first-page":"9099","DOI":"10.1073\/pnas.1602185113","article-title":"Stress and corticosteroids regulate rat hippocampal mitochondrial DNA gene expression via the glucocorticoid receptor","volume":"113","author":"Hunter RG","year":"2016","unstructured":"Hunter RG, Seligsohn M, Rubin TG, Griffiths BB, Ozdemir Y, Pfaff DW, Datson NA, McEwen BS (2016) Stress and corticosteroids regulate rat hippocampal mitochondrial DNA gene expression via the glucocorticoid receptor. Proc Natl Acad Sci U S A 113(32):9099\u20139104. 10.1073\/pnas.1602185113","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"ref32","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.bbamcr.2011.05.014","article-title":"Glucocorticoids induce mitochondrial gene transcription in HepG2 cells: role of the mitochondrial glucocorticoid receptor","volume":"1813","author":"Psarra AM","year":"2011","unstructured":"Psarra AM, Sekeris CE (2011) Glucocorticoids induce mitochondrial gene transcription in HepG2 cells: role of the mitochondrial glucocorticoid receptor. Biochim Biophys Acta 1813(10):1814\u20131821. 10.1016\/j.bbamcr.2011.05.014","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"ref33","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1172\/JCI112722","article-title":"Effect of dexamethasone on hepatic glucose and insulin metabolism after oral glucose in conscious dogs","volume":"78","author":"Chap Z","year":"1986","unstructured":"Chap Z, Jones RH, Chou J, Hartley CJ, Entman ML, Field JB (1986) Effect of dexamethasone on hepatic glucose and insulin metabolism after oral glucose in conscious dogs. J Clin Invest 78(5):1355\u20131361. 10.1172\/JCI112722","journal-title":"J Clin Invest"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"960279","DOI":"10.3389\/fendo.2022.960279","article-title":"Dexamethasone-associated metabolic effects in male mice are partially caused by depletion of endogenous corticosterone","volume":"13","author":"Koorneef LL","year":"2022","unstructured":"Koorneef LL, van der Meulen M, Kooijman S, Sanchez-Lopez E, Scheerstra JF, Voorhoeve MC, Ramesh ANN, Rensen PCN, Giera M, Kroon J, Meijer OC (2022) Dexamethasone-associated metabolic effects in male mice are partially caused by depletion of endogenous corticosterone. Front Endocrinol (Lausanne) 13:960279. 10.3389\/fendo.2022.960279","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"ref35","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/archpedi.153.8.795","article-title":"Lipid intolerance in neonates receiving dexamethasone for bronchopulmonary dysplasia","volume":"153","author":"Amin SB","year":"1999","unstructured":"Amin SB, Sinkin RA, McDermott MP, Kendig JW (1999) Lipid intolerance in neonates receiving dexamethasone for bronchopulmonary dysplasia. Arch Pediatr Adolesc Med 153(8):795\u2013800. 10.1001\/archpedi.153.8.795","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"9","key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092328","article-title":"Dexamethasone-Induced Adipose Tissue Redistribution and Metabolic Changes: Is Gene Expression the Main Factor? An Animal Model of Chronic Hypercortisolism","volume":"10","author":"Fatima Silva F","year":"2022","unstructured":"de Fatima Silva F, Komino ACM, Andreotti S, Boltes Reis G, Caminhotto RO, Landgraf RG, de Souza GO, Sertie RAL, Collins S, Donato J Jr., Bessa Lima F (2022) Dexamethasone-Induced Adipose Tissue Redistribution and Metabolic Changes: Is Gene Expression the Main Factor? An Animal Model of Chronic Hypercortisolism. Biomedicines 10(9). 10.3390\/biomedicines10092328","journal-title":"Biomedicines"},{"issue":"2","key":"ref37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1203\/pdr.0b013e31802d89ff","article-title":"Postnatal treatment with dexamethasone perturbs hepatic and cardiac energy metabolism and is associated with a sustained atherogenic plasma lipid profile in suckling rats","volume":"61","author":"Liu Y","year":"2007","unstructured":"Liu Y, Havinga R, Bloks VW, Baller JF, van der Leij FR, Reijngoud DJ, Sauer PJ, Kuipers F (2007) Postnatal treatment with dexamethasone perturbs hepatic and cardiac energy metabolism and is associated with a sustained atherogenic plasma lipid profile in suckling rats. Pediatr Res 61(2):165\u2013170. 10.1203\/pdr.0b013e31802d89ff","journal-title":"Pediatr Res"},{"issue":"2","key":"ref38","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1210\/en.2007-1214","article-title":"Effect of dexamethasone on glucose tolerance and fat metabolism in a diet-induced obesity mouse model","volume":"149","author":"Gounarides JS","year":"2008","unstructured":"Gounarides JS, Korach-Andre M, Killary K, Argentieri G, Turner O, Laurent D (2008) Effect of dexamethasone on glucose tolerance and fat metabolism in a diet-induced obesity mouse model. Endocrinology 149(2):758\u2013766. 10.1210\/en.2007-1214","journal-title":"Endocrinology"},{"issue":"7","key":"ref39","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.celrep.2017.01.014","article-title":"FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice","volume":"18","author":"Fu Z","year":"2017","unstructured":"Fu Z, Gong Y, Liegl R, Wang Z, Liu CH, Meng SS, Burnim SB, Saba NJ, Fredrick TW, Morss PC, Hellstrom A, Talukdar S, Smith LE (2017) FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice. Cell Rep 18(7):1606\u20131613. 10.1016\/j.celrep.2017.01.014","journal-title":"Cell Rep"},{"issue":"4","key":"ref40","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3945\/ajcn.114.099291","article-title":"Dietary omega-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin","volume":"101","author":"Fu Z","year":"2015","unstructured":"Fu Z, Lofqvist CA, Shao Z, Sun Y, Joyal JS, Hurst CG, Cui RZ, Evans LP, Tian K, SanGiovanni JP, Chen J, Ley D, Hansen Pupp I, Hellstrom A, Smith LE (2015) Dietary omega-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin. Am J Clin Nutr 101(4):879\u2013888. 10.3945\/ajcn.114.099291","journal-title":"Am J Clin Nutr"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.preteyeres.2014.11.004","article-title":"Retinal microglia: just bystander or target for therapy?","volume":"45","author":"Karlstetter M","year":"2015","unstructured":"Karlstetter M, Scholz R, Rutar M, Wong WT, Provis JM, Langmann T (2015) Retinal microglia: just bystander or target for therapy? Prog Retin Eye Res 45:30\u201357. 10.1016\/j.preteyeres.2014.11.004","journal-title":"Prog Retin Eye Res"},{"issue":"7432","key":"ref42","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature11862","article-title":"Metabolism of inflammation limited by AMPK and pseudo-starvation","volume":"493","author":"O'Neill LA","year":"2013","unstructured":"O'Neill LA, Hardie DG (2013) Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493(7432):346\u2013355. 10.1038\/nature11862","journal-title":"Nature"},{"issue":"1","key":"ref43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2006.05.011","article-title":"Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation","volume":"4","author":"Vats D","year":"2006","unstructured":"Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, Morel CR, Wagner RA, Greaves DR, Murray PJ, Chawla A (2006) Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab 4(1):13\u201324. 10.1016\/j.cmet.2006.05.011","journal-title":"Cell Metab"},{"issue":"3","key":"ref44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cmet.2019.06.005","article-title":"A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease","volume":"30","author":"Baik SH","year":"2019","unstructured":"Baik SH, Kang S, Lee W, Choi H, Chung S, Kim JI, Mook-Jung I (2019) A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease. Cell Metab 30(3):493\u2013507e496. 10.1016\/j.cmet.2019.06.005","journal-title":"Cell Metab"},{"issue":"4","key":"ref45","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cmet.2022.02.013","article-title":"Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer's disease","volume":"34","author":"Pan RY","year":"2022","unstructured":"Pan RY, He L, Zhang J, Liu X, Liao Y, Gao J, Liao Y, Yan Y, Li Q, Zhou X, Cheng J, Xing Q, Guan F, Zhang J, Sun L, Yuan Z (2022) Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer's disease. Cell Metab 34(4):634\u2013648e636. 10.1016\/j.cmet.2022.02.013","journal-title":"Cell Metab"},{"issue":"2","key":"ref46","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/jnc.14267","article-title":"Hexokinase 2-dependent hyperglycolysis driving microglial activation contributes to ischemic brain injury","volume":"144","author":"Li Y","year":"2018","unstructured":"Li Y, Lu B, Sheng L, Zhu Z, Sun H, Zhou Y, Yang Y, Xue D, Chen W, Tian X, Du Y, Yan M, Zhu W, Xing F, Li K, Lin S, Qiu P, Su X, Huang Y, Yan G, Yin W (2018) Hexokinase 2-dependent hyperglycolysis driving microglial activation contributes to ischemic brain injury. J Neurochem 144(2):186\u2013200. 10.1111\/jnc.14267","journal-title":"J Neurochem"},{"issue":"1","key":"ref47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-021-02187-y","article-title":"Early glycolytic reprogramming controls microglial inflammatory activation","volume":"18","author":"Cheng J","year":"2021","unstructured":"Cheng J, Zhang R, Xu Z, Ke Y, Sun R, Yang H, Zhang X, Zhen X, Zheng LT (2021) Early glycolytic reprogramming controls microglial inflammatory activation. J Neuroinflammation 18(1):129. 10.1186\/s12974-021-02187-y","journal-title":"J Neuroinflammation"},{"issue":"10","key":"ref48","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/s42255-022-00643-4","article-title":"Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to beta-amyloid clearance","volume":"4","author":"Leng L","year":"2022","unstructured":"Leng L, Yuan Z, Pan R, Su X, Wang H, Xue J, Zhuang K, Gao J, Chen Z, Lin H, Xie W, Li H, Chen Z, Ren K, Zhang X, Wang W, Jin ZB, Wu S, Wang X, Yuan Z, Xu H, Chow HM, Zhang J (2022) Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to beta-amyloid clearance. Nat Metab 4(10):1287\u20131305. 10.1038\/s42255-022-00643-4","journal-title":"Nat Metab"},{"issue":"23","key":"ref49","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.160940","article-title":"Single-cell transcriptome analyses reveal microglia types associated with proliferative retinopathy","volume":"7","author":"Liu Z","year":"2022","unstructured":"Liu Z, Shi H, Xu J, Yang Q, Ma Q, Mao X, Xu Z, Zhou Y, Da Q, Cai Y, Fulton DJ, Dong Z, Sodhi A, Caldwell RB, Huo Y (2022) Single-cell transcriptome analyses reveal microglia types associated with proliferative retinopathy. JCI Insight 7(23). 10.1172\/jci.insight.160940","journal-title":"JCI Insight"},{"issue":"555","key":"ref50","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1371","article-title":"Glycolysis links reciprocal activation of myeloid cells and endothelial cells in the retinal angiogenic niche","volume":"12","author":"Liu Z","year":"2020","unstructured":"Liu Z, Xu J, Ma Q, Zhang X, Yang Q, Wang L, Cao Y, Xu Z, Tawfik A, Sun Y, Weintraub NL, Fulton DJ, Hong M, Dong Z, Smith LEH, Caldwell RB, Sodhi A, Huo Y (2020) Glycolysis links reciprocal activation of myeloid cells and endothelial cells in the retinal angiogenic niche. Sci Transl Med 12(555). 10.1126\/scitranslmed.aay1371","journal-title":"Sci Transl Med"},{"issue":"3","key":"ref51","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cmet.2014.07.011","article-title":"Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization","volume":"20","author":"Jin Z","year":"2014","unstructured":"Jin Z, Wei W, Yang M, Du Y, Wan Y (2014) Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell Metab 20(3):483\u2013498. 10.1016\/j.cmet.2014.07.011","journal-title":"Cell Metab"},{"issue":"D1","key":"ref52","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol Y","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C, Garcia-Seisdedos D, Hewapathirana S, Kamatchinathan S, Kundu DJ, Prakash A, Frericks-Zipper A, Eisenacher M, Walzer M, Wang S, Brazma A, Vizcaino JA (2022) The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res 50(D1):D543\u2013D552. 10.1093\/nar\/gkab1038","journal-title":"Nucleic Acids Res"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4619093\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4619093\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T14:10:42Z","timestamp":1719324642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4619093\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":52,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4619093\/v1","relation":{},"subject":[],"published":{"date-parts":[[2024,6,25]]},"subtype":"preprint"}}